Due to the small number of BRAF-mutated CRC with MSI-H/dMMR and a favorable prognosis of MSI-H/dMMR, statistical power is to be limited, and these studies might have underestimated the negative prognosis of BRAF-mutated CRCs with MSI-H/dMMR. Here, BRAF is linked to colorectal carcinoma.